Stockreport

$10.9 Billion Attention Deficit Hyperactivity Disorder (ADHD) Opportunity Assessment and Forecasts 2022-2024 & 2032: Epidemiology, Symptoms, Diagnosis, Disease Management, Revenue, Unmet N...

Cingulate Inc.  (CING) 
PDF The ADHD therapeutics market, valued at $11.9 billion in the 2022 baseline year, is expected to encounter a negative compound annual growth rate (CAGR) of 0.9%, ultimat [Read more]